Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.150
+0.150 (3.75%)
May 2, 2025, 4:00 PM EDT - Market closed
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $34.29 million as of May 2, 2025. Its market cap has increased by 163.15% in one year.
Market Cap
34.29M
Enterprise Value
10.25M
1-Year Change
163.15%
Ranking
Category
Stock Price
$4.15
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $34.29M, a decrease of -52.93%. That is a compound annual growth rate of -19.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 2, 2025 | 34.29M | 5.24% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 807.25B |
| Johnson & Johnson | 376.09B |
| UnitedHealth Group | 374.50B |
| AbbVie | 345.13B |
| Novo Nordisk | 293.18B |
| Abbott Laboratories | 226.76B |
| Novartis AG | 223.05B |
| AstraZeneca | 221.80B |